Targeted Therapy Thwarts Tumor Progression : Sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.March 15, 2006Gastroenterology
Earlier Colorectal Screening Urged for Key Groups : African Americans, diabetics, and female smokers are found to be at substantially above-average risk.February 15, 2006Gastroenterology
Genetic Polymorphism Test Could Identify Barrett's Patients at Risk for ProgressionFebruary 1, 2006Gastroenterology
